The home of OpenAI CEO Sam Altman, where he stays with his family, was hit by a Molotov cocktail. Police have reportedly arrested a 20-year-old in connection with the attack on the AI boss’ luxury San ...

Ahead of the Season 3 premiere on Sunday, the show’s creator discussed his reputation, the loss of Angus Cloud and the soul-searching that followed. Ahead of the Season 3 premiere on Sunday, the ...

A person was taken into custody after allegedly throwing a Molotov cocktail at OpenAI Chief Executive Sam Altman’s home and making threats at the company’s San Francisco headquarters, a spokeswoman ...

Jo Adell goes into the stands for his third home run robbery of the game Saturday night. Ryan Sirius Sun / Getty Images ANAHEIM, Calif. — There was a brief moment of silence amid the chaos Saturday ...

The man who allegedly threw an incendiary device at the home of OpenAI CEO Sam Altman is facing attempted murder and attempted arson charges, authorities said Monday. Daniel Moreno-Gama, a 20-year-old ...

Emily Sherman is a staff loans writer for Buy Side, covering personal, auto, student and business loans. She has been writing about personal finance and higher education topics for the past eight ...

Police in San Francisco have arrested a 20-year-old man after a Molotov cocktail was thrown at the home of OpenAI CEO Sam Altman, setting a perimeter gate alight. Officers responded to a call in the ...

Meagan is a former Series 7 financial advisor and current writer focused on blending straightforward information with a dose of humor on topics including equity investments, insurance products, and ...

This is read by an automated voice. Please report any issues or inconsistencies here. Hours after a Molotov cocktail was thrown at his San Francisco home, OpenAI Chief Executive Sam Altman addressed ...

TAMPA, Fla. (WFLA) — The Artemis II crew is headed home. They orbited the moon, and got great photos of it, and even got a shot of the Milky Way. But this mission is about more than taking photos.

Formation Bio CEO Ben Liu is convinced that drug discovery isn’t the bottleneck in getting medicines to market—it’s going through clinical trials. Now he’s raised some $615 million from top investors ...